Recent News

• 08.06.2026 - Retina Development: The Next Era of Precision Therapies Is Here
• 07.29.2026 - Inside the Lab: Advancing Clinical Trials Across Asia-Pacific and Greater China – Q&A with Paul Tan, PhD
• 07.23.2026 - Alport Research Hub Symposium: From Bench to Bedside
• 07.07.2026 - Behind the Breakthroughs: Rare Disease Q&A with Lauren Shannon
• 06.30.2026 - Inside the Lab: Spotlight on Molecular Innovation – Q&A with El Mustapha Bahassi, PhD
• 06.04.2026 - Advancing Gene Therapy Innovation in Ophthalmology Trials
• 06.01.2026 - Expert Perspectives on the Transforming Diabetes Clinical Trial Landscape
• 05.27.2026 - Inside the Lab: Building Histology Capabilities for Modern Clinical Trials – Q&A with Rob McGee, MD, PhD
• 05.26.2026 - Q&A with Medpace’s Two New Neurology Experts
• 05.21.2026 - Raising The Standard in Pediatric Migraine Clinical Trials

Recent Filings

• 08.07.2026 - 144 Report of proposed sale of securities
• 07.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.29.2026 - 144/A Report of proposed sale of securities
• 07.28.2026 - 144 Report of proposed sale of securities
• 07.28.2026 - 144 Report of proposed sale of securities
• 07.27.2026 - 144 Report of proposed sale of securities
• 07.23.2026 - 144 Report of proposed sale of securities
• 07.23.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.22.2026 - EX-99.1 EX-99.1